VIRTUS

Serial Number 86587871
Registration 5111954
702

Registration Progress

Application Filed
Apr 6, 2015
Under Examination
Approved for Publication
Oct 18, 2016
Published for Opposition
Oct 18, 2016
Registered
Jan 3, 2017

Trademark Image

VIRTUS

Basic Information

Serial Number
86587871
Registration Number
5111954
Filing Date
April 6, 2015
Registration Date
January 3, 2017
Published for Opposition
October 18, 2016
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
702
Status Date
Sep 8, 2023
Registration
Registered
Classes
005 035 042

Rights Holder

Virtus Pharmaceuticals, LLC

16
Address
12 Penns Trail
Newtown, PA 18940

Ownership History

Virtus Pharmaceuticals, LLC

Original Applicant
16
Tampa, FL

Virtus Pharmaceuticals, LLC

Owner at Publication
16
Tampa, FL

Virtus Pharmaceuticals, LLC

Original Registrant
16
Newtown, PA

Legal Representation

Attorney
Laurence Tauber

USPTO Deadlines

Next Deadline
532 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2017-01-03)
Due Date
January 03, 2027
Grace Period Ends
July 03, 2027

Application History

43 events
Date Code Type Description Documents
Sep 8, 2023 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Sep 8, 2023 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Sep 8, 2023 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Mar 10, 2023 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Jan 3, 2022 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Jan 11, 2017 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jan 11, 2017 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jan 3, 2017 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 18, 2016 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 18, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 28, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 14, 2016 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Sep 1, 2016 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 31, 2016 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Aug 31, 2016 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Aug 31, 2016 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Aug 31, 2016 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Aug 15, 2016 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 15, 2016 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 13, 2016 ALIE A ASSIGNED TO LIE Loading...
Aug 5, 2016 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Aug 4, 2016 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Aug 4, 2016 PETG O PETITION TO REVIVE-GRANTED Loading...
Aug 4, 2016 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 18, 2016 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 18, 2016 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Feb 3, 2016 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 3, 2016 GNRT O NON-FINAL ACTION E-MAILED Loading...
Feb 3, 2016 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 20, 2016 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 20, 2016 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 20, 2016 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 21, 2015 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 21, 2015 GNRT O NON-FINAL ACTION E-MAILED Loading...
Jul 21, 2015 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 20, 2015 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 20, 2015 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jul 20, 2015 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 14, 2015 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 30, 2015 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Apr 30, 2015 TAEA I TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED Loading...
Apr 14, 2015 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 9, 2015 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals, namely, prescription and over-the-counter drugs for the treatment of illness, disease or deficiencies, namely, bacterial infections, treatment symptoms of seasonal, perennial and chronic allergies and the treatment of skin hives and itching associated with skin reactions, Type 2 diabetes mellitus, Treatment and prevention of osteoporosis in postmenopausal women, treatment to increase bone mass in men with osteoporosis, treatment of glucocorticoid induced osteoporosis, Treatment of Paget's Disease of bone, Treatment for the relief of discomfort associated with acute or painful musculoskeletal conditions, Treatment and management of moderate to moderately-severe pain in adults, Treatment of hypertension, Treatment of diabetic nephropathy, Treatment of dermatitis herpetiformis and leprosy, Treatment of chronic inflammatory skin disease marked by blisters, Treatment of acid indigestion, Treatment of upset stomach, Management and support for patients requiring increased folate levels, Supplementation in support of bone health, Supplementation in support of prenatal health, including, without limitation, increased folic acid, Management and support of absorption of calcium and/or functioning of calcium in the body, Treatment of Vitamin D deficiency, Supplementation in support of postnatal health, Treatment and prevention of lack of vitamins, minerals and/or fatty acids during pregnancy, Treatment and temporary relief of cough, nasal congestion, loosening of phlegm and thin bronchial secretions, Treatment and prevention of prenatal and postnatal folate deficiency, Treatment of elevated or high levels of uric acid and prevention and treatment of metabolic problems caused by kidney disease, prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets, hormone replacement therapy, Postnatal supplementation and improvement of nutritional states of women prior to conception, prevention of acidosis, stomach or bowel problems, peptic ulcers and irritable bowel syndrome, Treatment for excessive saliva production, irritable colon and bladder dysfunction, Treatment of symptoms associated with disorders of gastrointestinal tract, bladder spasms, peptic ulcer disease, diverticulitis, irritable bowel syndrome, cystitis and pancreatitis, Prevention and treatment of low blood levels of potassium, Prevention of Fetal Neural Tube Defects when pregnant, Treatment of inadequate folic acid, folate deficiency, and anemia from inadequate folic acid, Treatment of Hyperhomocysteinemia
First Use Anywhere: Oct 1, 2011
First Use in Commerce: Oct 1, 2011
Class 035
Distributorship services in the field of prescription and over-the-counter drugs; marketing of prescription and over-the-counter drugs
First Use Anywhere: Oct 1, 2011
First Use in Commerce: Oct 1, 2011
Class 042
Development of pharmaceutical products
First Use Anywhere: Oct 1, 2011
First Use in Commerce: Oct 1, 2011

Classification

International Classes
005 035 042